fbpx
GeneralResearch & Publications

Prevalence of Dyslipidemias in Three Regions in Venezuela: The VEMSOLS Study Results

By January 1, 2018September 24th, 2020No Comments

LINK TO RESEARCH
https://pubmed.ncbi.nlm.nih.gov/29538522/

PUBLICATION
Arquivos Brasileiros de Cardiologia

AUTHORS
#N/A

ABSTRACT
Background: The prevalence of dyslipidemia in multiple regions of Venezuela is
unknown. The Venezuelan Metabolic Syndrome, Obesity and Lifestyle Study
(VEMSOLS) was undertaken to evaluate cardiometabolic risk factors in
Venezuela.
Objective: To determine the prevalence of dyslipidemia in five populations from three
regions of Venezuela.
Methods: During the years 2006 to 2010, 1320 subjects aged 20 years or older were
selected by multistage stratified random sampling from all households in
five municipalities from 3 regions of Venezuela: Lara State (Western
region), Merida State (Andean region), and Capital District (Capital
region). Anthropometric measurements and biochemical analysis were obtained
from each participant. Dyslipidemia was defined according to the
NCEP/ATPIII definitions.
Results: Mean age was 44.8 ± 0.39 years and 68.5% were females. The prevalence of
lipids abnormalities related to the metabolic syndrome (low HDL-c [58.6%;
95% CI 54.9 – 62.1] and elevated triglycerides [39.7%; 36.1 – 43.2]) were
the most prevalent lipid alterations, followed by atherogenic dyslipidemia
(25.9%; 22.7 – 29.1), elevated LDL-c (23.3%; 20.2 – 26.4),
hypercholesterolemia (22.2%; 19.2 – 25.2), and mix dyslipidemia (8.9%; 6.8
– 11.0). Dyslipidemia was more prevalent with increasing body mass index.
Conclusion: Dyslipidemias are prevalent cardiometabolic risk factors in Venezuela.
Among these, a higher prevalence of low HDL is a condition also
consistently reported in Latin America.

——–

Interested in this research and working with us? Please contact us here.